ABCA1 and metabolic dysfunction-associated steatotic liver disease: Ma et al. [20] used baicalein to regulate the PPARγ/LXRα/ABCA1 signalling pathway to reduce liver function injury and inflammatory infiltration and improve glucose and lipid metabolism and insulin resistance in NAFLD rats.